- Filed
- Nov 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 29, 2025 | 91.49M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 105.52M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 103.04M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 102.59M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 102.68M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $82.12M |
| Stock Repurchased | Q3 2025 · Sep 30, 2024 | $29.88M |
| Capex | Q3 2025 · Sep 30, 2025 | $102.93M |
| Capex | Q3 2025 · Sep 30, 2024 | $132.89M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $252.32M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $211.39M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $1.28B |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $1.49B |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $9.5M |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $0 |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $236.56M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $428.45M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $439.87M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$69.62M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$175.22M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$202.96M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | −$211.7M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | −$253.78M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | −$313.7M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $325M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $220.96M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $1.8B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $1.84B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $367.63M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $541.72M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $1.73B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $1.64B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $1.51 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $2.31 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $0.33 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $0.70 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $1.74 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $2.56 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $0.36 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $0.72 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $32.65M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $101.86M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $40.42M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $127.03M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $38.12M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $117.36M |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $36.28M |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $102.19M |
| Net Income | Q3 2025 · Sep 30, 2025 | $158.37M |
| Net Income | Q3 2025 · Sep 30, 2025 | $233.6M |
| Net Income | Q3 2025 · Sep 30, 2024 | $32.95M |
| Net Income | Q3 2025 · Sep 30, 2024 | $66.23M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $44.93M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $118.19M |
| Operating Income | Q3 2025 · Sep 30, 2024 | $24.61M |
| Operating Income | Q3 2025 · Sep 30, 2024 | $58.47M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $136.93M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $397.32M |
| Gross Profit restated | Q3 2025 · Sep 30, 2024 | $116.56M |
| Gross Profit restated | Q3 2025 · Sep 30, 2024 | $339.86M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $92.7M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $261.72M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $81.92M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $235.83M |
| Revenue | Q3 2025 · Sep 30, 2025 | $229.63M |
| Revenue | Q3 2025 · Sep 30, 2025 | $659.04M |
| Revenue | Q3 2025 · Sep 30, 2024 | $198.48M |
| Revenue | Q3 2025 · Sep 30, 2024 | $575.69M |